CN Patent

CN112047939B — 一种具有抗肿瘤活性的四氢吡啶并嘧啶类化合物

Assigned to Jiangsu Simcere Pharmaceutical Co Ltd · Expires 2023-05-02 · 3y expired

What this patent protects

本发明提供了一种式(I)所示的四氢吡啶并嘧啶类化合物或其药学上可接受的盐，含有它们的药物组合物以及其在制备预防和/或治疗针对KRAS G12C突变肿瘤药物中的应用。

USPTO Abstract

本发明提供了一种式(I)所示的四氢吡啶并嘧啶类化合物或其药学上可接受的盐，含有它们的药物组合物以及其在制备预防和/或治疗针对KRAS G12C突变肿瘤药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN112047939B
Jurisdiction
CN
Classification
—
Expires
2023-05-02
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Simcere Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.